Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CBGL Technical Analysis https://www.barchart.com/stocks/quotes/CBGL/technical-analysis
$CBGL Traders Cheat Sheet https://cannabisglobalinc.com/new-brand-botan/
$CBGL Traders Cheat Sheet https://cannabisglobalinc.com/new-brand-botan/
$CBGL Our New Family “Botan” long expected new cannabis brand.
https://cannabisglobalinc.com/new-brand-botan/
$CBGL Our New Family “Botan” long expected new cannabis brand.
https://cannabisglobalinc.com/new-brand-botan/
$CBGL Cannabis Global Completes Significant Debt Cancellations in Q1 - Over $800K in Debt Extinguishment - Actively Negotiating Additional Debt Settlements
https://feeds.issuerdirect.com/news-release.html?newsid=7256443189477382
$CBGL Cannabis Global Completes Significant Debt Cancellations in Q1 - Over $800K in Debt Extinguishment - Actively Negotiating Additional Debt Settlements
https://feeds.issuerdirect.com/news-release.html?newsid=7256443189477382
On watch for an update here.
CBGL
Same here Bud.
CBGL
$CBGL Some of our projects involve: hemp cultivation of up to 100 acres, unique powdered cannabis drinks product line and intellectual properties including patents and trademarks.
$CBGL Latest updates https://cannabisglobalinc.com/blog/
$CBGL Latest updates https://cannabisglobalinc.com/blog/
$CBGL Check out the talented management team: https://cannabisglobalinc.com/management/
$CBGL Check out the talented management team: https://cannabisglobalinc.com/management/
$CBGL CGI and Botan LLC is renewing their related dispensaries.
Cannabis Global Inc and Botan LLC is renewing their related dispensaries stationed in down town LA( 837 S Los Angeles St and 2038 Sacramento St. Los Angeles) to new conceptual store named Cannamart in which the venue will offer cannabis brands a booths inside.
$CBGL CGI and Botan LLC is renewing their related dispensaries.
Cannabis Global Inc and Botan LLC is renewing their related dispensaries stationed in down town LA( 837 S Los Angeles St and 2038 Sacramento St. Los Angeles) to new conceptual store named Cannamart in which the venue will offer cannabis brands a booths inside.
$CBGL is a global player in the fast growing and highly lucrative cannabis marketplace headquartered in bustling Downtown Los Angeles, California. The Company will be involved in both the industrial hemp markets, where permitted and legal under the 2018 Farm Bill, and the legal marijuana markets as permitted and licensed by way of various state and local laws and regulations.
$CBGL is a global player in the fast growing and highly lucrative cannabis marketplace headquartered in bustling Downtown Los Angeles, California. The Company will be involved in both the industrial hemp markets, where permitted and legal under the 2018 Farm Bill, and the legal marijuana markets as permitted and licensed by way of various state and local laws and regulations.
$CBGL is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.
$CBGL is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.
$CBGL Cannabis Global is a publicly traded company focused on delivering long-term shareholder growth and results. We invest with confidence and determination to be the forefront of the cannabis and CBD revolution.
https://cannabisglobalinc.com/
$CBGL Cannabis Global is a publicly traded company focused on delivering long-term shareholder growth and results. We invest with confidence and determination to be the forefront of the cannabis and CBD revolution.
https://cannabisglobalinc.com/
$CBGL The Company indicates it has entered into additional debt settlement negotiations aimed at further reducing the Company’s debt burden, which it anticipates will be completed over the next fiscal quarter.
https://www.morningstar.com/news/globe-newswire/8810613/cannabis-global-files-latest-quarterly-report-receives-additional-debt-cancellations
$CBGL The Company indicates it has entered into additional debt settlement negotiations aimed at further reducing the Company’s debt burden, which it anticipates will be completed over the next fiscal quarter.
https://www.morningstar.com/news/globe-newswire/8810613/cannabis-global-files-latest-quarterly-report-receives-additional-debt-cancellations
$CBGL The Company believes that these debt restructurings and settlements will go a long way to demonstrate to its investors and potential financiers, Cannabis Global’s potential in the California cannabis sector and provide a better position for what the Company’s executives believe, will soon be a true nationwide market for our products and services. These debt reductions will also help reduce future market dilution and help support a healthier market cap and enterprise value.
https://www.barrons.com/articles/cannabis-global-files-latest-quarterly-report-receives-additional-debt-cancellations-f1668406?mod=md_stockoverview_news
$CBGL The Company believes that these debt restructurings and settlements will go a long way to demonstrate to its investors and potential financiers, Cannabis Global’s potential in the California cannabis sector and provide a better position for what the Company’s executives believe, will soon be a true nationwide market for our products and services. These debt reductions will also help reduce future market dilution and help support a healthier market cap and enterprise value.
https://www.barrons.com/articles/cannabis-global-files-latest-quarterly-report-receives-additional-debt-cancellations-f1668406?mod=md_stockoverview_news
$CBGL During the second fiscal quarter, the Company announced the successful conclusion of debt settlement negotiations with two debtholders, eliminating approximately $813,000 of long-term debt from the Company’s balance sheet. In April of 2022, the Company entered into a cannabis cultivation joint venture where Cannabis Global issued a note as payment for specific tasks to be completed by the joint venture. Due to rapidly falling prices for cannabis biomass, the cultivation effort never materialized. The parties to the joint venture agreed on terms of the note cancellation to benefit both entities.
“We continue to restructure our balance sheet to create additional value for our shareholders,” commented Edward Manolos, CEO of Cannabis Global. “There is undoubtedly tremendous turmoil in the California cannabis markets, but we continue our commitment to the cannabis marketplace and fully expect to emerge as a more vital organization. This additional $421,000 cancellation will allow us to present a stronger balance sheet to the marketplace and meaningfully further our restructuring program.”
https://www.marketwatch.com/press-release/cannabis-global-files-latest-quarterly-report---receives-additional-debt-cancellations-2023-04-18?mod=mw_quote_news_seemore
$CBGL During the second fiscal quarter, the Company announced the successful conclusion of debt settlement negotiations with two debtholders, eliminating approximately $813,000 of long-term debt from the Company’s balance sheet. In April of 2022, the Company entered into a cannabis cultivation joint venture where Cannabis Global issued a note as payment for specific tasks to be completed by the joint venture. Due to rapidly falling prices for cannabis biomass, the cultivation effort never materialized. The parties to the joint venture agreed on terms of the note cancellation to benefit both entities.
“We continue to restructure our balance sheet to create additional value for our shareholders,” commented Edward Manolos, CEO of Cannabis Global. “There is undoubtedly tremendous turmoil in the California cannabis markets, but we continue our commitment to the cannabis marketplace and fully expect to emerge as a more vital organization. This additional $421,000 cancellation will allow us to present a stronger balance sheet to the marketplace and meaningfully further our restructuring program.”
https://www.marketwatch.com/press-release/cannabis-global-files-latest-quarterly-report---receives-additional-debt-cancellations-2023-04-18?mod=mw_quote_news_seemore
$CBGL Cannabis Global, Inc. (OTC PINK: CBGL), a licensed Los Angeles-based manufacturer and distributor in the cannabis sector, today announces the filing of its quarterly report for the fiscal quarter ending February 28, 2023, and additional debt cancellations designed to strengthen the corporate balance sheet. Cannabis Global remains compliant relative to the reporting requirements for public quoting under Rule 15c2-11.
https://www.nasdaq.com/press-release/cannabis-global-files-latest-quarterly-report-receives-additional-debt-cancellations
$CBGL Cannabis Global, Inc. (OTC PINK: CBGL), a licensed Los Angeles-based manufacturer and distributor in the cannabis sector, today announces the filing of its quarterly report for the fiscal quarter ending February 28, 2023, and additional debt cancellations designed to strengthen the corporate balance sheet. Cannabis Global remains compliant relative to the reporting requirements for public quoting under Rule 15c2-11.
https://www.nasdaq.com/press-release/cannabis-global-files-latest-quarterly-report-receives-additional-debt-cancellations
$CBGL Cannabis Global Files Latest Quarterly Report – Receives Additional Debt Cancellations
https://finance.yahoo.com/news/cannabis-global-files-latest-quarterly-190200342.html
$CBGL Cannabis Global Files Latest Quarterly Report – Receives Additional Debt Cancellations
https://finance.yahoo.com/news/cannabis-global-files-latest-quarterly-190200342.html
$EMED Management notes that 2023 will see the launch of the WellnessPro Infinity™, continued expansion in its sales team, a strong focus on value-add strategic partnerships, research partnerships and further customer affordability strategies as the Company monetizes its market-leading next-generation drug-free pain therapy technology.
$EMED Management notes that 2023 will see the launch of the WellnessPro Infinity™, continued expansion in its sales team, a strong focus on value-add strategic partnerships, research partnerships and further customer affordability strategies as the Company monetizes its market-leading next-generation drug-free pain therapy technology.
$EMED As the Company moves closer to production of the new next-generation flagship device, management plans to offer a special upgrade and exchange program to existing clients, which will be bundled with a lifetime warranty.
$EMED As the Company moves closer to production of the new next-generation flagship device, management plans to offer a special upgrade and exchange program to existing clients, which will be bundled with a lifetime warranty.
$EMED Matthew Wolfson, Founder and CEO commented, "Q4 was a breakout quarter. We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance. Overall, it was our best quarter since we went public and provides strong market feedback that our next-generation R&D and market positioning represents the start of an exciting new chapter for Electromedical. And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."
$EMED Matthew Wolfson, Founder and CEO commented, "Q4 was a breakout quarter. We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance. Overall, it was our best quarter since we went public and provides strong market feedback that our next-generation R&D and market positioning represents the start of an exciting new chapter for Electromedical. And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."
$EMED During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.